

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Mycophenolic Acid
Therapeutic Area : Ophthalmology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Mycophenolic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dry Eye Syndromes.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 02, 2021
Lead Product(s) : Mycophenolic Acid
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Mycophenolic Acid
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : Novartis Pharmaceuticals Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients
Details : Mycophenolic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 15, 2011
Lead Product(s) : Mycophenolic Acid
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : Novartis Pharmaceuticals Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Mycophenolic Acid
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Novartis Pharmaceuticals Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Myfortic (Mycophenolic Acid) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Nephrotic Syndrome.
Product Name : Myfortic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 09, 2010
Lead Product(s) : Mycophenolic Acid
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Novartis Pharmaceuticals Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Mycophenolic Acid
Therapeutic Area : Immunology
Study Phase : Phase IV
Sponsor : Novartis Pharmaceuticals Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Details : Myfortic (Mycophenolic Acid) is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Kidney Transplantation.
Product Name : Myfortic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 24, 2010
Lead Product(s) : Mycophenolic Acid
Therapeutic Area : Immunology
Highest Development Status : Phase IV
Sponsor : Novartis Pharmaceuticals Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
